FDA Investigator Almaris N Alonso
Almaris N Alonso has inspections in 4 countries as of 03 Aug 2023. Almaris N Alonso has collaborated with a combined 1234 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
03 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
France,
Germany,
Sweden
Co-Investigator(s):
A Williams,
Abby E Pelletier,
Alissa E Berryman,
Allison A Rodriguez,
Amy C Jordan,
Ashley M Whitehurst,
Christine L Williams,
Christopher T Middendorf,
Constance Desimone,
Daryl A Dewoskin,
Douglas S Joslin,
Hala L Selby,
Irons,
Jacqueline S Warner,
James I Giefer,
Javier O Vega,
Jennifer L Huntington,
Jonathan B Lewis,
Jose Acruz Gonzalez,
Joyce A Kellett,
Justin A Boyd,
Justine M Corson,
Kevin D Kallander,
Kim Lthomas Cruse,
Kristina J Donohue,
Kristina M Joyce,
Lauren M Lawrance,
LCDR Debra Emerson,
Mark C Lookabaugh,
Mark E Farrell,
Mary Jeanet Mcgarry,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Michael P Sweeney,
Michele Perry Williams,
Michelle M Noe,
Mra B Kamberem,
Mra Davism,
Nicholas B Murphy,
Nichole B Murphy,
Nicole E Knowlton,
Pal S Mayasandra,
Pamela L Lee,
Pamela L Ogonowski,
Paul L Bellamy,
Paula J Bretz,
Philip Kreiter,
Ramon E Martinez,
Raymond T Oji,
Richard H Penta,
Richard L Friedman,
Richard L Licari,
Rodney G Raiford,
Rory K Geyer,
Salvatore N Randazzo,
Sarah A Hassas,
Shamel Jaime,
Sina Shojaee,
Slater K Bartlett,
Stacey S Degarmo,
State Agency,
Steven P Donald,
Steven R Ziser,
Susan M Jackson,
Susanne M Richardson, MSc RAC ELS,
Thomas W Nerney,
Wendy A Johnecheck,
William J Leonard
Almaris N Alonso's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2013 | EIR | Advanced Medical Optics Uppsala AB - EIR, 2013-09-06 |
November, 2012 | FDA 483 | Ameridose, LLC - Form 483, 2012-11-09 |
October, 2012 | FDA 483 | New England Compounding Pharmacy, Inc. - Form 483, 2012-10-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more